相关实验视频
Updated: Aug 28, 2025

15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
9.7K
肌缩性侧面硬化
Eva L Feldman1, Stephen A Goutman1, Susanne Petri2
1Department of Neurology, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
Lancet (London, England)
|September 18, 2022
概括
随着新的诊断标准和对其复杂性质的理解, 肌缩侧面硬化症 (ALS) 的治疗正在得到改善. 在病理生理学,生物标志物和治疗方面的进步为改善患者的结果提供了希望.
科学领域:
- 神经科学
- 神经学
背景情况:
- 肌缩侧面硬化 (ALS) 是一种致命的中枢神经系统 (CNS) 神经退行性疾病,目前的治疗方法不足.
- 现象异质性和全球中枢神经系统功能障碍是ALS的特征,需要改进诊断和预后方法.
研究的目的:
- 概述最近关于ALS病理生理学,诊断和预后的见解.
- 讨论神经病学家对ALS治疗的现状和未来前景.
主要方法:
- 关于ALS异质性,遗传学和病理生理学的当前研究的审查.
- 对新的诊断标准,生物标志物,风险因素和预测模型进行分析.
- 检查基于机制的临床试验管道.
主要成果:
- 认定ALS是一种复杂的综合征正在影响临床实践.
- 在了解ALS方面取得的进步正在澄清它的范围,
- 新的洞察力正在改变预后格局,
结论:
- 尽管面临挑战, 新兴的研究在临床上为ALS带来了切实的效果.
- 未来的前景包括改善肌缩性侧面硬化症患者的护理和治疗结果.
- 继续研究ALS病理生理学和治疗方法对于临床进展至关重要.
相关概念视频
Cross-bridge Cycle
118.1K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
118.1K
Parkinson's Disease: Overview
677
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
677
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Disorders of the Skeletal Muscle
1.0K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.0K
Chemical Synapses
9.0K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.0K
Myasthenia Gravis: Overview and Treatment
1.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.8K

